Literature DB >> 28765936

Human cytomegalovirus miR-US4-5p promotes apoptosis via downregulation of p21-activated kinase 2 in cultured cells.

Yaozhong Shao1, Ying Qi1, Yujing Huang1, Zhongyang Liu1, Yanping Ma1, Xin Guo1, Shujuan Jiang1, Zhengrong Sun1, Qiang Ruan1.   

Abstract

The human cytomegalovirus (HCMV) encodes ≥26 microRNAs (miRNAs). These miRNAs are utilized by HCMV to regulate its own genes in addition to the genes of the host cell, during infection. The present study first identified p21‑activated kinase 2 (PAK2) as a target of hcmvmiR‑US4‑5p, via hybrid polymerase chain reaction, which was further verified using a luciferase reporter assay. The protein expression level of PAK2, detected via western blotting, was demonstrated to be directly downregulated by overexpression of hcmvmiR‑US4‑5p in HEK293, HELF and THP‑1 cells. Furthermore, it was demonstrated that the PAK2 protein level in naturally infected HELF cells was gradually decreased at 24, 48 and 72 h post infection with increased hcmvmiR‑US4‑5p expression. The use of PAK2‑specific small interfering RNA and an inhibitor for hcmvmiR‑US4‑5p, demonstrated that the promotion of apoptosis by hcmvmiR‑US4‑5p in these cells was specifically mediated via inhibition of PAK2 expression. These results indicated that hcmvmiR‑US4‑5p may exhibit this activity during natural HCMV infection, in order to establish a balance between the host cell and virus.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28765936     DOI: 10.3892/mmr.2017.7108

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  MicroRNAs expressed by human cytomegalovirus.

Authors:  Lichen Zhang; Jiaqi Yu; Zhijun Liu
Journal:  Virol J       Date:  2020-03-12       Impact factor: 4.099

2.  Different expression pattern of human cytomegalovirus-encoded microRNAs in circulation from virus latency to reactivation.

Authors:  Wanqing Zhou; Cheng Wang; Meng Ding; Yuying Bian; Yujie Zhong; Han Shen; Junjun Wang; Chen-Yu Zhang; Chunni Zhang
Journal:  J Transl Med       Date:  2020-12-09       Impact factor: 5.531

3.  Human Cytomegalovirus miR-UL70-3p Downregulates the H2O2-Induced Apoptosis by Targeting the Modulator of Apoptosis-1 (MOAP1).

Authors:  Abhishek Pandeya; Raj Kumar Khalko; Anup Mishra; Nishant Singh; Sukhveer Singh; Sudipta Saha; Sanjay Yadav; Sangeeta Saxena; Sunil Babu Gosipatala
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 4.  microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells.

Authors:  Mengyao Yu; Yuexinzi Jin; Shichang Zhang; Jian Xu; Jiexin Zhang
Journal:  Vaccines (Basel)       Date:  2022-01-19

Review 5.  The Role of CMV Infection in Primary Lesions, Development and Clinical Expression of Atherosclerosis.

Authors:  Carmen Valentina Cristescu; Sophie Alain; Simona Maria Ruță
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

6.  Hcmv-miR-UL148D regulates the staurosporine-induced apoptosis by targeting the Endoplasmic Reticulum to Nucleus signaling 1(ERN1).

Authors:  Abhishek Pandeya; Raj Kumar Khalko; Sukhveer Singh; Manish Kumar; Sunil Babu Gosipatala
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

Review 7.  HCMV miRNA Targets Reveal Important Cellular Pathways for Viral Replication, Latency, and Reactivation.

Authors:  Nicole L Diggins; Meaghan H Hancock
Journal:  Noncoding RNA       Date:  2018-10-22

8.  STARD4 promotes breast cancer cell malignancy.

Authors:  Min Zhang; Zhen Xiang; Feng Wang; Rong Shan; Ling Li; Juan Chen; Bao-An Liu; Juan Huang; Lun-Quan Sun; Wei-Bing Zhou
Journal:  Oncol Rep       Date:  2020-10-12       Impact factor: 3.906

Review 9.  The Emerging Role of Non-Coding RNAs in the Regulation of Virus Replication and Resultant Cellular Pathologies.

Authors:  Soudeh Ghafouri-Fard; Bashdar Mahmud Hussen; Hazha Hadayat Jamal; Mohammad Taheri; Guive Sharifi
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.